Canopy Growth Corporation (CGC)
|Net Income (ttm)||146.88M|
|Trading Day||January 26|
|Day's Range||33.18 - 36.15|
|52-Week Range||9.73 - 36.15|
Martha Stewart wants to help pet owners turn dog days into dog daze.
SMITHS FALLS, ON, Jan. 26, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter f...
Lifestyle guru Martha Stewart has done it all--from books and television to kitchenware and home decor lines--and now, she's adding CBD dog treats to her empire.
It's good news all around for the marijuana marketers.
Canopy Growth Corp welcomed aboard Marth Stewart as an advisor back in February 2019. In September, the collaboration yielded a line of hemp-derived supplements.
Lifestyle guru Martha Stewart on Tuesday launched a line of cannabis-infused oil drops and soft-baked chews for dogs, months after the successful release of her cannabidiol (CBD) gummie treats...
He's more than a little bullish on the U.S. pot market.
Martha Stewart's CBD for Pet line features science-backed, gourmet-flavored CBD soft-chews and oil drops for dogs and carries the NASC Quality Seal SMITHS FALLS, ON and NEW YORK, Jan. 26, 2021...
Cannabis Watch: Cannabis stocks slide as investors lock in gains driven by hopes that Biden will usher in reforms
Cannabis stocks were mostly lower Monday as investors locked in some of the market's recent gains amid continued optimism for the sector following record sales in 2020 and as more states look ...
These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for February.
Why this analyst thinks marijuana's market could be worth $40B
Vivien Azer, Cowen senior research analyst, joins 'The Exchange' to discuss her outlook for pot stocks and how the legislative approval timeline could affect marijuana-related stocks.
Less than 48 hours after informing it would move its U.S. stock listing from the New York Stock Exchange to the Nasdaq Global Select Market, Canadian cannabis giant Canopy Growth Corp. announc...
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient fundin...
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks over the past week, and look ahead to how the cannabis...
The beer and spirits distributor intends to cash in on the premiumization trend.
Canadian cannabis company Canopy Growth Corp. on Thursday filed an early warning report on Thursday relating to an option it has acquired, which if exercised, would give it a greater than 10% ...
ACQUISITION OF OPTION TO MAINTAIN PRO RATA OWNERSHIP INTEREST OF APPROXIMATELY 20% FOLLOWING TERRASCEND FINANCING SMITHS FALLS, ON, Jan. 14, 2021 /PRNewswire/ - Canopy Growth Corporation ("Can...
Medical pot is now legal in Mexico.
These growers are facing mounting losses year after year.
Although sales were up in Q2, there are still many question marks for investors to consider before buying this pot stock.
Canopy's stock is already up over 18% since the start of the year, and has recovered nicely since the sudden bear market in March of 2020 when it hit single digit prices.
These cannabis stocks currently have the most green.
A cannabis CEO makes a bullish prediction on marijuana legalization in 2021.
The rapidly growing cannabis industry now has 10 companies at or above a $2 billion market cap.
The Canadian marijuana company has positioned itself well to take advantage of the potentially immense market.
Now that the Democrats' 'Blue Wave' is here, Biden can bring sweeping reform to cannabis and clean energy. It's time to buy these nine stocks!
A Democratic Senate victory could be huge for cannabis reform. But U.S. legalization won't happen overnight, and CGC stock is the best play for now.
All eyes are on a still undecided race in Georgia, but the vote to buy is already in for these select cannabis stocks The post 3 Cannabis Stocks to Own Right Now appeared first on InvestorPlac...
There's no denying that 2021 will be a tricky year to navigate. But if you're feeling confident, here are some growth stocks to buy.
Cannabis stocks rallied anew on Thursday, with the Cannabis ETF on track for its biggest weekly gain since March of 2020, as hopes the Democrat's victory in the Georgia Senate run-off will spu...
Canopy Growth, the largest marijuana stock, rebounded as Georgia Senate runoffs fueled hopes for cannabis legalization. Is CGC stock a buy right now?
Democratic taking control of both House and Senate, these investing strategies should prosper in the coming days.
There were plenty of positive developments that should have pushed shares higher.
Its $10 billion valuation is more than triple the market cap of both merging companies -- combined.
Cannabis stocks are ready to ride favorable legal developments to huge gains in the decade ahead. The post 3 Cannabis Stocks to Buy for the ‘Blue Wave' Catalyst appeared first on InvestorPlace.
The cannabis industry could be cheering louder than the Democrats.
Investors in the cannabis sector are feeling pretty good today.
The shares of several cannabis stocks are trading higher Wednesday in anticipation of results from Georgia's runoff election. A democratic win would be seen as favorable for cannabis legalizat...
Predicting market moves proves difficult again, but cannabis investors have high hopes for the future.
Pot stocks move higher as Democrats lead in Georgia run-off election
Michael Lavery, Piper Sandler senior analyst, joins "Squawk on the Street" to discuss pot stocks as Democrats lead in both Georgia Senate races.
The marijuana industry's growth could be about to accelerate.
Cannabis Watch: Cannabis stocks stage strong rally as prospect of Democratic Senate spurs reform hopes
Cannabis stocks staged a strong rally on Wednesday, with most Canadian and U.S. companies posting double-digit percentage gains, buoyed by hopes the Democrats may take the Senate and pursue a ...
Pot stocks rallied on Wednesday as Georgia's Senate runoff elections lifted investors' hopes for nationwide decriminalization. Democrats are set to win both races in Georgia and win a slim maj...
Cannabis stocks surged on Wednesday as Democrats won a key U.S. Senate race in Georgia and led in another, moving closer to a stunning sweep that would give them control of Congress and power ...
Cannabis stocks Tilray, Canopy Growth and ACB are up in double digits as the Georgia runoff elections appear to flip the U.S. Senate blue. The post Cannabis Stocks: Why TLRY, CGC and ACB Stock...
The final weeks of 2020 brought a host of market-shaking headlines. However, one major headline only received a brief moment of scrutiny before getting subsumed by news of federal stimulus an...
With marijuana decriminalization potentially on the horizon, investors may wonder if now is a good time to buy pot stocks.
Cannabis stocks rallied in premarket trade Wednesday, on hopes the Democrats may take the Senate after Raphael Warnock won one of two Senate runoffs in Georgia early Wednesday, according to th...
Marijuana bills have come to die in the Senate, but that could change if there's a shift in power.
Cannabis stocks like CGC and ACB stock are on the move Monday ahead of the Georgia Senate runoff races. Here's what to know.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSt... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |
In 2019, Canopy Growth's revenue was 398.77 million, an increase of 76.18% compared to the previous year's 226.34 million. Losses were -1.32 billion, 79.5% more than in 2018.